OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← National Kidney Federation

2023-12-31-accounts

Registered number: 05272349 Charity numbers: 1106735 & SC049431

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

CONTENTS

Page
Reference and Administrative Details of the Charity, its Trustees and Advisers 1 - 2
Trustees' Report 3 - 16
Independent Auditor's Report on the Financial Statements 17 - 21
Statement of Financial Activities 22
Balance Sheet 23 - 24
Statement of Cash Flows 25
Notes to the Financial Statements 26 - 46

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2023

Trustees R A Aird
S Khurana (appointed 22 April 2023)
C Sepede (appointed 22 April 2023)
C Bryant, Co Vice Chair
P S Constable
B M Child, Secretary
D Coyle, Chairman
R J Higgins, Chairman (resigned 22 April 2023)
G Molina (appointed 22 April 2023, resigned 19 January 2024)
K K Y Lim (resigned 22 April 2023)
T Paul, Co Vice Chair
N Plange
J Roberts
M J Sinfield, Treasurer

Company registered number 05272349 Charity registered numbers 1106735 and SC049431 Registered office The Point Coach Road Shireoaks Worksop Nottinghamshire S81 8BW

Page 1

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

President K Modi Chief Executive A Brown Independent auditor Streets Audit LLP Tower House Lucy Tower Street Lincoln Lincolnshire LN1 1XW Bankers Lloyds Bank plc 202 High Street Lincoln LN5 7AP Solicitors Foys Solicitors 102 Bridge Street Worksop Nottinghamshire S80 1HZ

Page 2

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023

The Trustees present their annual report together with the audited financial statements of the Charity for the period from 1 January 2023 to 31 December 2023. The Annual Report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the Charity qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Objectives and activities

a. Policies and objectives

The charity has the objectives of promoting throughout the United Kingdom the best renal medical practice and treatment, the health of persons suffering from kidney disease or renal failure, and to support the related needs of those relatives or friends who care for kidney patients.

The NKF is a national umbrella organisation for the local Kidney Patient Associations (KPAs) that are located in renal units or hospitals throughout the UK. The NKF is unique in the field of kidney charities in that it is run by kidney patients for kidney patients. All members of the NKF Executive Committee are kidney patients themselves or carers of kidney patients, as well as representing a Kidney Patient Association (KPA). Being a patient or carer brings the advantage of experience of living with the disease. Being able to speak from their own experience and empathise with others in the same situation brings definite strength to statements made by the charity and helps it push forward for better treatments as well as giving practical advice based on real experience.

The NKF has been representing and advocating on behalf of renal patients for 45 years, with a focus of providing national patient support services, and campaigning for improvements to renal provision and treatment.

The NKF run the only UK Helpline dedicated solely to patients with the condition. Kidney disease can affect anyone of any age, even from birth. There are currently around three and a half million people with early stage Chronic Kidney Disease (CKD) in the UK, and around 63,000 with end-stage disease: meaning they are either on dialysis or have had a kidney transplant, or are receiving palliative care. NKF offers these patients, their families and carers the information, advocacy and support that is needed.

The Charity has the responsibility of representing and assisting the work of Kidney Patient Associations (KPAs) as well as encouraging prospective KPAs to be formed helping to promote a wider knowledge and understanding of the problems of kidney patients, and those relatives or friends who care for them, to the general public and the appropriate authorities; and to advocate on their behalf.

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.

Page 3

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Objectives and activities (continued)

b. Volunteers

Much work is undertaken by volunteers, this includes fundraising and serving on NHS and other committees. Each Executive member also undertakes voluntary activities for the charity in addition to their work as trustees and members of Local Kidney Patient Associations.

These volunteers have given an estimated 2,000 hours of their time this year, to supporting the charity’s activities with and for kidney patients.

These volunteers play an essential role in the life of the charity. Without their generous volunteering, the work in support of kidney patients would not be as effective.

c. Main activities undertaken to further the Charity's purposes for the public benefit

When planning the year’s activities the Executive and management have taken into account the Charity Commissioner’s guidance on public benefit. The NKF supports all kidney patients and their carers across the UK particularly focussing on the issues and difficulties often faced by those on dialysis and those on the waiting list or those having had a transplant, but also aims to support all those who have had a diagnosis of chronic kidney disease. As well as providing advice to individuals, NKF advocates for best practice and treatments to be offered to all kidney patients from the NHS and actively lobbies government and others on their behalf.

Achievements and performance

a. Main achievements of the Charity

The charity carries out a wide range of activities in pursuance of its charitable aims. The trustees consider that these activities, summarised below, provide benefit to members of the Kidney Patient Associations and to those with chronic kidney disease in the wider community, as well as education of the general public.

Helpline

In 2023 the Helpline had another very busy year sending out many thousands of resources including leaflets, information packs, and patient cards.

Linda and Stephen continue to promote Helpline as much as possible with posters, flyers, and contacting the renal units.

The Helpline sent out 27,000 leaflets to units and patients, over 2000 patient support packs, and over 1000 patient information folders which include leaflets on dialysis, transplants, diet exercise, and on CKD stage 3. The information packs made up by the Helpline in the office are very popular.

Page 4

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

The Helpline in 2023 had over 5000 contacts from patients, carers, renal units, and individuals which is an increase of 6.7% compared with 2022 The Helpline continues to grow and is a very popular service with patients and renal hospitals.

The most common inquiries to the Helpline in 2023

  1. CKD

  2. Medical advice

  3. Dialysis

  4. Diet and Exercise

  5. Transplants

The most popular leaflets/information packs sent out in 2023

  1. Dialysis Information

  2. Dietary Information

  3. Transplant information

  4. CKD Information 5. Exercise Information

The Helpline was pleased to add 16 new titles to our information library in 2023 these are listed below. 1) Calciphylaxis

7) Healthy eating for people with Chronic Kidney disease (written by the Renal Nutrition Group)

8) Medication for immunosuppression and prevention of kidney infections in patients (written by an Advanced Clinical Pharmacist)

9) Commonly Taken drugs for kidney failure (written by a Specialist Pharmacist for Nephrology and Transplant.)

10) Over-the-counter drugs and natural medicines and supplements (written by a Renal Pharmacist)

11) End-of-life care (written in 2023 by Dr Jyoti Baharani)

12) Conservative Management

13) Holiday/ travel vaccinations in transplanted patients (written by Lead Pharmacist Manchester Royal Infirmary)

14) NKF Home Dialysis Peer Support Booklet, our brand-new information leaflet about our peer support service and the benefits of doing home therapies.

15) Phosphate in your Diet (provided by the Renal Nutrition Group)

16) Exercise for Kidney Patients (written and developed by Leicester Kidney Lifestyle Team and the NKF Helpline)

The NKF Peer Support Service

We now have 21 peer supporters with four new volunteers to be trained in February 2024. The new supporters will help us cover other areas of home therapies and kidney disease. They include a couple of parents who have children with kidney disease, and a 20-year-old patient with experience in home dialysis and another male supporter who has experience in PD and managing his work and family life around his dialysis.

We produced a 16-page booklet in 2023 to explain our peer support service and how to contact the service. We included information on what home therapy is, shared care, and the benefits as well as some testimonials from our peer supporters and from patients who had used our service. The booklet was very popular with renal units and KPA’s and we sent just over 2000 of these out.

Page 5

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

Stephen from the Helpline also did two talks to promote the peer support service and the NKF helpline one for KQUIP in Warrington and another for Fresenius at their annual function of all the Fresenius clinic lead nurses at Bawtry.

Campaigning and Lobbying

All Party Parliamentary Kidney Group (APPKG)

The NKF continues to serve as secretariat to the APPKG. The first APPKG meeting was held in January 2023, the Annual General Meeting was chaired by Laura Farris MP. The meeting raised topics on organ donation and transplantation as well as the future of renal improvements in the health and care services. The APPKG was joined by National Medical Director of NHS England and Professor of Renal Medicine at University College London, Professor Stephen Powis, and Director of Organ Donation and Transplantation, Antony Clarkson. The next APPKG meeting was held in March 2023, this was a Parliamentary Reception, hosted by the National Kidney Federation in collaboration with AstraZeneca, Fresenius Medical Care and Healthy.io. The event was held a day before World Kidney Day, to emphasise the importance of early detection of chronic kidney disease with MPs. On the day there were urine tests available to all eligible parliamentarians with medical professionals on hand, blood pressure tests to raise awareness of good kidney health, and three different types of dialysis machines which were demonstrated during the afternoon.

The event was a great success to showcase what the charity can provide as an insight to improve prevention, diagnosis and treatment of kidney disease. Guest speakers from the event included: Dr Raj Thakkar, discussing chronic kidney disease and early detection, Funmi Lawal, a kidney patient with renal failure which was caused by high blood pressure during pregnancy, Katie Vinen, Clinical Vice President of the UK Kidney Association (UKKA) and Kidney Doctor and Clare Morlidge, Co-President of UK Kidney Association and Renal Pharmacist, who spoke on behalf of the UKKA. An ITN production programme launch on Understanding Kidney Health in collaboration with the NKF was also featured at the reception. Also launched at the Parliamentary Reception event was the National Kidney Federation report, 'Home Dialysis in the Context of COVID-19 in the UK – Two years on’, to showcase the latest home dialysis data findings and responses from devolved governments and clinical directors. Over 35 MPs and 75 Peers attended the event in Parliament and met representatives from around the country.

The National Kidney Federation also joined the All-Party Parliamentary Kidney Group (APPKG) Meeting on supporting mental health for kidney patients at Portcullis House, London in October. The meeting was once again chaired by Laura Farris MP. Kidney Research UK and Centre for Mental Health also joined the group to address the mental health challenges of life with kidney disease.

Full details of the group can be found here - https://www.kidney.org.uk/all-party-parliamentary-group

Education and Communication

Kidney Life:

The quarterly Kidney Life magazine is highly rated for those who are patients, carers and medical professionals to receive renal news and announcements. The magazine has an array of medical information. Subjects such as renal diet and fundraising events are a regular feature as well as stories from patients themselves. The magazine is posted quarterly to over 14,000 people, but many thousands also download and read it from the website. Items this year have included articles regarding the APPKG updates, promotion of the NKF Helpline and Peer Support Service, an introduction to our new Chairman, David Coyle, KPA Day, UK Kidney Week Annual Patients’ Event, celebrating the 45th Anniversary of the National Kidney Federation and 40 years of Kidney Life magazine and many patient stories.

Page 6

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

Website:

The website is growing from strength to strength which is a massive resource for patients and the NKF have also seen a lot of people donating through the website. NKF’s end goal remains the same, having all the information needed for kidney patients and their families and to provide the support that they need. The Helpline information page is continuously being added to, including information on how to order dialysis and transplant patient emergency cards. Pages are being revamped and more content is being added all the time enabling kidney patients and their families/carers to have all the information they need on one site. After two years, it is evident that the accessibility feature on the National Kidney Federation website has become a widely used tool. Our objective remains to enhance equality, diversity, and inclusion on our website. Thanks to the assistive toolbar, we have been able to personalise our site, thereby making it more accessible. The most well-liked features have created interest from over 20 languages, such as Greek, Hungarian, Persian, Western Frisian, Armenian, Arabic, Polish, Bengali, Albanian, Urdu, Czech, Icelandic, Afrikaans, Albanian, Indonesian, and Punjabi.

Social Media:

NKF posts nearly every day on their social media channels. These can include light-hearted posts, patient stories about their diagnosis, their transplant story or how they became a living donor, to dialysis as well as NHS and Government information. The social media channels continue to attract engagement. The NKF have over 13,600 followers on Facebook, Twitter, Instagram, YouTube and LinkedIn combined compared to 11,000 followers the year prior.

In Touch:

We are proud to say that our free monthly e-newsletter continues to be produced in-house with over 12,000 subscribers reading the publication. One of our favourite sections of the newsletter is ‘Kidney Patient Association of the Month’, where we explore the history of a particular KPA and take in an insight into how they support kidney patients within their local areas. In addition to this, we also share upcoming activities such as our NKF webinar series, KPA Day, Annual Patients’ Event and World Kidney Day, plus our charity’s achievements, renal industry updates and patient support. Like the Kidney Life magazine, it is published online via our website www.kidney.org.uk in an enhanced ‘flip page’ digital format via ISSUU.

Events and Social Activities

All these are designed both to give information and to enable patients and their carers to come together. The latter is particularly important, as by its very nature and treatment, dialysis limits patients in social activities. These events enable people to come together, share experiences and give valuable ‘tips’ in helping others manage their condition.

A selection of these included:-

Annual Patient Event

The Annual Patients’ Event was the first face-to-face event for the NKF since the COVID-19 pandemic stalled all within the world, it took place on 22nd – 23rd September 2023. It was a memorable achievement celebrating the charity’s 45th Anniversary, as well as celebrating all of the Kidney Patient Associations that have been around for even longer. The day included guest speakers including professional and patient speakers and it was a success with many in attendance. The event can be viewed here: www.kidney.org.uk/Event/national-kidney-federationannual-patients-event-2023

Page 7

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

KPA Day

NKF’s KPA Day took place on Saturday 22nd April 2023 as a face-to-face event. There was good attendance and we had great speakers. The new NKF executive committee was elected at the Annual General Meeting and the NKF Council meeting was held. More highlights from the day can be found here: www.kidney.org.uk/kpa-day2023-face-to-face-event

Organ Donation Summit

The National Kidney Federation (NKF), National Black, Asian, Mixed Race and Minority Ethnic (BAME) Transplant Alliance (NBTA), and the Jain and Hindu Organ Donation Alliance (JHOD) marked the three-year anniversary of the organ donation opt out law held at the City Hall in London on 19th May 2023 hosted by Assembly Member Krupesh Hirani.

A panel of guest speakers presented the latest statistics on organ donation and transplantation and how ethnic minority community groups are taking action to address inequalities in provision. The summit revealed that there has been limited change in law for several reasons and the consent rate of family members who agree to donate the organs of loved family members after death has gone down from 72% in 2020 to 70% in 2022. This reduction is also present in the consent rates among Asian and Black potential donors. Six recommendations emerged from the summit and can be found here: www.kidney.org.uk/news/national-charities-express-concern-overimpact-of-the-organ-donation-law-change-to-opt-out

British Transplant Games

The British Transplant Games took place in Coventry, on the final day of the event. NKF Helpline Advisor, Stephen Emmerson and NKF Communications and Marketing Officer, Sharney Warren attended the event networking with the rest of the kidney charities present. The NKF team met many new and familiar faces and were on hand to provide more knowledge about what the charity has to offer in terms of patient support, including handing out emergency transplant and Helpline cards, transplant wristbands, hats and water bottles.

World Kidney Day (WKD)

WKD was held on Thursday 9th March 2023. NKF collaborated with the Kidney Charities Together Group (Kidney Care, Kidney Research UK, UK Kidney Association, PKD and Kidney Wales), to run a campaign for WKD. Kidney Patient Associations and hospitals reached out to the general public about the importance of kidney health. An agency was used once again to continue the campaign with the charities. The campaign was successful and NKF will continue to raise awareness of this important day each year. The 2023 campaign involved a two day immersive pop-up event experience at Leicester Highcross Shopping Centre, offering visitors the chance to understand the daily challenges of living with kidney disease. The immersive event used UV technology to give visitors an insight into what living with kidney disease is like. Based inside an everyday kitchen, guests were able to interact with ultraviolet LED technology to uncover aspects of life with kidney disease that are typically hidden. A significant amount of positive attention from Leicester Highcross Shopping Centre with a weekend footfall of 61,538 visitors. 3,200 kidney information leaflets were handed out in Leicester.

Page 8

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

b. Factors relevant to achieve objectives- Covid 19

Covid-19

Sadly, COVID-19 has remained to be a main constant in our daily life. Despite this, the National Kidney Federation amongst the Kidney Charities Together (KCT) (Kidney Research UK, Kidney Care UK, PKD Charity, Kidney Wales and the UK Kidney Association) have continued to evolve and adapt our ways of working together as we learn to live alongside the virus. The main goal of their meetings is to create clear guidance for renal patients. We have also been there every step of the way to support the NHS, spreading their messages far and wide to our community. The NKF website is relied upon by many for the latest information on COVID-19: www.kidney.org.uk/News/coronavirus-latest-information-and-advice

UK Kidney Week

The National Kidney Federation returned to the annual UK Kidney Week (UKKW) event at the International Convention Centre, Newport, Wales in June 2023. The conference included up-to-date research, latest information lectures, networking with clinicians, academics, scientists, kidney charities and trainees. As usual, the NKF Helpline leaflets were on display at the event for renal units and healthcare professionals to take samples and order in bulk. The NKF presented three sessions titled ‘Peer Support in Renal Services’ with Popham Kidney Support, chaired by Nicki Thomas and Eleri Wood. John Roberts, member of the NKF Executive Committee and member of Hope KPA and Jeff Wood, NKF Peer Supporter discussed the NKF’s National Home Dialysis Patient Support Service and explored how the services work and the benefits it opens to patients to consider the idea of dialysis at home. And Pete Revell, NKF Head of Marketing and Fundraising, represented the National Kidney Federation by chairing a talk regarding anaemia and how it affects kidney patients. The session was titled; ‘The burden of symptoms, do we really understand the everyday reality of living with Anaemia of Chronic Kidney Disease?’ organised and funded by GSK.

Renal Services Transformation Programme (RSTP) and NHS England Clinical reference Group

The RSTP headed by NHS England commenced its work during 2021 and continued during 2023, to transform renal services.

RSTP is currently in the process of developing a comprehensive communications and engagement strategy to outline the next phase of the programme that will facilitate use of the RSTP Dashboard and Toolkit across systems. NKF have worked closely with the RSTP board and programme since its inception in 2021.

NHS England’s Clinical Reference Group’s National Clinical Director is Professor Smeeta Sinha, NKF have frequent meetings with the RSTP and NHS England leads to discuss areas of concern or where they can work together to better patients’ experiences. New national service specifications are currently being written.

Page 9

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

c. Fundraising activities and income generation

As we reflect on the challenges and successes of the past year, we are pleased to share with you the fundraising highlights and achievements of 2023. Despite the difficulties posed by the cost-of-living crisis, we witnessed the generosity and support of our supporters, making a significant impact on our fundraising efforts.

Key Highlights:

Our fundraising campaigns, Best Foot Forward and Choctober, outperformed the previous year, generating increased income. The dedication of our supporters contributed significantly to these successes.

Trust Partnerships:

Building on the success of last year's trust funding, we have engaged a trust and grant consultant to oversee our applications. This approach will hopefully enhance our ability to secure vital support from trusts.

Legacy Income:

Legacy income achieved remarkable success, marking the second-highest figure since the inception of our charity. The charity now offers a free Will writing service and regularly promotes legacy giving, this will hopefully ensure the income will continue to be at a high level.

Supporter Donations:

While donations from supporters experienced a slight dip compared to the previous year, we are grateful for the contributions that came through general donations, shop sales, direct debits, and in-memory collections.

Clothes Collections Success:

UK Clothes collections witnessed another fruitful year in terms of income. Both house-to-house collections and clothes banks across the UK contributed to this success.

Merchandise and Draw Ticket Income Growth:

Income from merchandise sales, including t-shirts, wristbands, and Christmas cards, saw an upturn compared to the previous year. Additionally, the NKF spring and winter draw ticket income showed positive growth.

England Transplant Football Association

The NKF are proud to work alongside the England Transplant Football Association. The club consists of volunteers from the transplant community, either organ recipients or transplant medical physicians. Including a professional coaching team from English Premier League or English Football League clubs.

The NKF provided a two-year sponsorship deal in 2023, enabling men and women to be more inclusive within transplant football, to provide more provisions, and create more opportunities to play transplant football. Their database has grown regionally, nationally and internationally since they launched in 2021, and have also been able to feed more new players to clubs and projects around the country thanks to NKF’s support.

Page 10

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Financial review

a. Going concern

After making appropriate enquiries, the trustees have a reasonable expectation that the charitable company has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements.

b. Reserves policy

The NKF Executive Committee recognise the importance of keeping sufficient reserves, particularly taking into account the anticipated significant increase in patients suffering from Chronic Kidney Disease (CKD) over the next 10 years. This is likely to increase demand from the Helpline and also increase the need for involvement in making representation to both the NHS and Government regarding provision of treatment of kidney disease.

Because of this it is felt prudent to set aside a Designated Fund of £150,000 to cover involvement with a major home therapies project over the next 5 years. Recognising that by working together with other charities and industry, the combined voice is likely to carry more weight with those tasked with funding and managing renal services in the UK.

There are also Endowment Funds amounting to £514,095 at the year end, and whilst these funds could be used for general purposes it is felt to be more prudent at this stage to retain these funds.

Given the difficulties of selling both the property and investments at short notice should the need arise it is felt prudent to set aside £350,000 of Unrestricted Funds to provide a cash reserve to cover any possible adverse movements in values.

In addition to this it is felt advisable to retain at least the equivalent of 12 months expenditure to fund ongoing activities and commitments and at the current level this equates to a need for an Unrestricted Reserve fund of £725,000. Currently the unrestricted fund balance at the year end is £2,102,319.

This will leave unallocated reserves of approximately £1 million at the year end and the Executive Committee are currently considering how this may best be used to support patients and to campaign for improvements to renal provision and treatment. A full strategy is in place, alongside this is a Development Plan. This has been drawn up for the charity with various initiatives identified that will require funding. The charity is also looking at funding by way of partnership or support and alongside other kidney charities projects that can be shown to have a clear benefit to kidney patients.

c. Material investments policy

The objective of the investment is to grow the capital of the charity while managing risk to a low to medium level and to provide for a capital growth requirement with the flexibility to produce income and allow extra deposits or withdrawals in the future as and when required. An ethical investment policy has been adopted which states that we will seek to avoid tobacco and alcohol stocks where practical within the pooled funds approach. The current year includes a gain on investments of £145,058 (2022: loss of £118,748).

Page 11

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

d. Principal risks and uncertainties

The building in Worksop is inspected regularly and a full health and safety audit is undertaken yearly, fire extinguishers are inspected and valid certificates displayed. Internal health and safety checks are conducted on a weekly basis. NKF has developed a full comprehensive risk register.

General Data Protection Regulations (GDPR) Policy has had an effect on most charities since its introduction. NKF continues to obtain permission from individuals to be able to process their personal data. The Database at the Head office allows personal data to be securely stored and to prevent breaches of information. The NKF has a new database this helps the charity maintain relationships with our supporters.

e. Principal funding

The financial statements for the year ended 31 December 2023 show a surplus of £301,011 (2022: £75,472) and total funds of £2,616,414 (2022: £2,315,403).

The Executive Committee will continue to carefully monitor the NKF budget, although the detailed line by line monitoring is done by the Finance and General Purposes Committee. The NKF has a healthy level of contingency funding set aside as cash, with the intent of moving this to a low risk investment portfolio. However, budget matters will continue to be given high priority in 2024.

Structure, governance and management

a. Constitution

The National Kidney Federation is constituted as a Company limited by guarantee. Set up in September 1978, the NKF registered with the Charity Commission for England and Wales on 27th January 1979, then reregistered with the Charity Commission in 2004, when it became an incorporated company, Charity Number 1106735.

The NKF registered as a charity with the Scottish Charity Regulator on 4th July 2019, Charity Number SC049431.

b. Methods of appointment or election of Trustees

The method of appointment to the Executive Committee is set out in the governing document ‘The Memorandum and Articles of Association’ The Executive Committee consists of not less than eleven and no more than sixteen members elected by representatives of full member KPAs of the Federation, including a maximum of six officers.

Up to three of the Trustees may be individuals who are members of the Federation, but may not be members of any KPA.

Page 12

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Structure, governance and management (continued)

c. Organisational structure and decision-making policies

The charity trustees – the Executive Committee, are responsible for the general governance of the charity. Management of the charity is delegated to the Chief Executive and her team.

The trustees give their time freely and receive no remuneration or other financial benefits (other than agreed expenses incurred in carrying out this role).

The following groups and sub committees have undertaken work on behalf of the Charity:

Finance and General Purposes Subcommittee

This subcommittee examines the current NKF Financial arrangements and ensures full compliancy with charity regulations and best practice. It considers appropriate policies, business plans, key staffing and governance matters in detail prior to making recommendations to the full Executive committee. The NKF budget is closely monitored by the subcommittee and financial recommendations are made to the Executive Committee.

The Event Subcommittee

The Patient Event Subcommittee decides upon a venue, speakers and a programme for the annual Patient Event and the KPA Day. NKF Staff source sponsorship from Industry Partners to cover the costs of these events.

Following the event, the committee meet in order to evaluate responses and to assess whether objectives for the event had been met and decide what the structure is for the next year’s event. The KPA Day and Patient Event are the main events of the NKF.

Home Dialysis Subcommittee

The mandate for this subcommittee is to monitor and push forward the five year increasing home dialysis campaign. All renal units have been asked to ensure that they have at least 20% of their patients dialysing at home. The progress of each renal unit is tracked and an annual report published with recommendations for increasing home therapies further. The reports are widely circulated. This campaign is to run for five years ending in 2025 with a manifesto for change to follow.

KPA Support Group

The subcommittee serves as a platform for maintaining ongoing communication and dialogue between KPAs and the NKF. This ensures that KPAs can express their needs, concerns, and suggestions effectively. By engaging with KPAs, the subcommittee works to identify the specific needs and challenges faced by individual associations. This could include issues related to membership growth, fundraising, advocacy efforts, or organisational development.

The subcommittee aims to support the growth and development of KPAs by providing them with resources, guidance, and assistance tailored to their specific needs. This may involve offering training sessions, sharing best practices, facilitating networking opportunities, or providing financial support.

For newly established KPAs, the subcommittee offers guidance and support throughout the setup process. The subcommittee also works to identify geographic areas or regions where there are no existing KPAs. This allows the NKF to target areas and potentially establish new KPAs, thereby expanding its reach and impact. Overall, this subcommittee plays a crucial role in fostering collaboration and support among KPAs, empowering them to effectively serve their members and advance the mission of the NKF. By facilitating communication, providing resources, and guiding organisational growth, the subcommittee helps strengthen the overall kidney patient community and enhance the impact of the NKF's work.

Staffing

At the year-end NKF had nine full time staff members and one part time staff member.

Page 13

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Structure, governance and management (continued)

d. Policies adopted for the induction and training of Trustees

The first meeting following the Annual General Meeting is in two parts, the first part is to induct new members and remind all members of their roles and responsibilities. All trustees are provided with an induction pack which includes the Memorandum & Articles of Association, Responsibilities of Charity Trustees. Financial Statements and Policy Statements etc. They are briefed on the code of practice for all trustees, their legal responsibilities, the content of the Memorandum & Articles of Association, decision making processes and recent financial performance. The induction also provides an opportunity to meet key employees and other trustees. Support to new members is also provided through a buddy arrangement.

e. Pay policy for key management personnel

The charity sets salary increases for staff after appraisals. Salaries are considered alongside budgets and approved by the executive committee.

f. Financial risk management

The Trustees have assessed the major risks to which the Charity is exposed, in particular those related to the operations and finances of the Charity, and are satisfied that systems and procedures are in place to mitigate exposure to the major risks.

The NKF now has a new database to ensure it is up to date and helps the charity with maintaining relationships with our supporters.

Page 14

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Plans for future periods

NKF Strategy

The NKF Executive Committee and the NKF staff team continued their work on the five year 2021 – 2026 Strategy.

A development plan was put into place for the year and lots of objectives were met. Most of them are detailed in the different sections of this annual report.

The strategy continues to help shape the future for the NKFs activities and objectives. The overview of the strategy can be read here: https://www.kidney.org.uk/nkf-strategy

Impact report

The NKF produced their third impact report for the year of 2022. The 2022 report was circulated with the summer issue of Kidney Life, in May 2023. Impact reports can be read here: www.kidney.org.uk/our-impact

Increasing Home Dialysis in the context of Covid-19

In March 2023, a year after the last NKF Home Dialysis Report, the NKF published the ‘Increasing Home Dialysis in the Context of COVID-19 in the UK Two Years On’ report. The purpose of the report is to share outcomes from the campaign in 2022 and to encourage the kidney community to take further action. The request to Clinical Directors of Renal Services in the UK resulted in responses from 31 units. A summary of the centre-by-centre responses are included within the Two Years On report and includes many examples of good practices that the NKF hopes will be helpful to everyone involved and interested in improving the provision of home dialysis in the UK. The details of the campaign and the reports can be found here: https://www.kidney.org.uk/home-dialysiscampaign.

Statement of Trustees' responsibilities

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Page 15

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Disclosure of information to auditor

Each of the persons who are Trustees at the time when this Trustees' Report is approved has confirmed that:

Auditor

The auditor, Streets Audit LLP, has indicated their willingness to continue in office. The designated Trustees will propose a motion reappointing the auditor at a meeting of the Trustees.

Approved by order of the members of the board of Trustees on 13 April 2024 and signed on their behalf by:

................................................ D Coyle (Chair of Trustees)

Page 16

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF NATIONAL KIDNEY FEDERATION

Opinion

We have audited the financial statements of National Kidney Federation (the 'charity') for the year ended 31 December 2023 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Page 17

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF NATIONAL KIDNEY FEDERATION (CONTINUED)

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's Report thereon. The Trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report.

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 and the Charities Accounts (Scotland) Regulations 2006 (as amended) require us to report to you if, in our opinion:

Page 18

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF NATIONAL KIDNEY FEDERATION (CONTINUED)

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Page 19

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF NATIONAL KIDNEY FEDERATION (CONTINUED)

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 44(1)(c) of the Charities and Trustee Investment (Scotland) Act 2005 and under the Companies Act 2006 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

Page 20

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF NATIONAL KIDNEY FEDERATION (CONTINUED)

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's Report.

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006, and to the charitable company's trustees, as a body, in accordance with regulation 10 of the Charities Accounts (Scotland) Regulations 2006. Our audit work has been undertaken so that we might state to the charitable company's members and Trustees those matters we are required to state to them in an Auditor's Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.

==> picture [126 x 53] intentionally omitted <==

Robert Anderson (Senior Statutory Auditor)

for and on behalf of Streets Audit LLP

Tower House Lucy Tower Street Lincoln Lincolnshire LN1 1XW

N.B. The date of signing should be entered in 'ACCOUNTS COMPLETION' section

Date: 13/05/2024

Streets Audit LLP are eligible to act as auditors in terms of section 1212 of the Companies Act 2006.

Page 21

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2023

Note
Income and
endowments from:
Donations and legacies
3
Charitable activities
4
Other trading activities
5
Investments
6
Total income and
endowments
Expenditure on:
Raising funds
7
Charitable activities
8
Total expenditure
Net income before
net gains/(losses) on
investments
Net gains/(losses) on
investments
Net movement in
funds
Reconciliation of
funds:
Total funds brought
forward
Net movement in funds
Total funds carried
forward		 Unrestricted
funds
2023
£
488,699
70,603
134,627
15,336
709,265
92,671
460,641
553,312
155,953
121,940
277,893
1,824,426
277,893
2,102,319		 Restricted
funds
2023
£
35,584
-
-
-
35,584
-
35,584
35,584
-
-
-
-
-
-		 Endowment
funds
2023
£
-
-
-
-
-
-
-
-
-
23,118
23,118
490,977
23,118
514,095		 Total
funds
2023
£
524,283
70,603
134,627
15,336
744,849
92,671
496,225
588,896
155,953
145,058
301,011
2,315,403
301,011
2,616,414		 Total
funds
2022
£
538,985
23,058
132,963
4,413
699,419
111,866
393,603
505,469
193,950
(118,478)
75,472
2,239,931
75,472
2,315,403

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 26 to 46 form part of these financial statements.

Page 22

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee) REGISTERED NUMBER: 05272349

BALANCE SHEET AS AT 31 DECEMBER 2023

Note
Fixed assets
Intangible assets
13
Tangible assets
14
Investments
15
Current assets
Debtors
16
Cash at bank and in hand
Creditors: amounts falling due within one
year
17
Net current assets
Total assets less current liabilities
Net assets excluding pension asset
Total net assets		 33,704
783,818
817,522
(28,724)		 2023
£
10,836
253,519
1,563,261
1,827,616
788,798
2,616,414
2,616,414
2,616,414		 32,563
639,244
671,807
(37,371)		 2022
£
12,384
263,664
1,404,919
1,680,967
634,436
2,315,403
2,315,403
2,315,403

Page 23

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee) REGISTERED NUMBER: 05272349

BALANCE SHEET (CONTINUED) AS AT 31 DECEMBER 2023

Note
Charity funds
Endowment funds
18
Unrestricted funds
18
Total funds		 2023
£
514,095
2,102,319
2,616,414		 2022
£
490,977
1,824,426
2,315,403

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on 13 April 2024 and signed on their behalf by:

D Coyle (Chair of Trustees)

The notes on pages 26 to 46 form part of these financial statements.

Page 24

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2023

Cash flows from operating activities
Net cash used in operating activities
Cash flows from investing activities
Dividends, interests and rents from investments
Purchase of investments
Net cash provided by investing activities
Cash flows from financing activities
Net cash provided by financing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
The notes on pages 26 to 46 form part of these financial statements		 2023
£
142,520
15,336
(13,282)
2,054
-
144,574
639,244
783,818		 2022
£
225,858
4,413
(2,927)
1,486
-
227,344
411,900
639,244

Page 25

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

1. General information

The company is a charity limited by guarantee, registered in England and Wales. The address of the registered office is The Point, Coach Road, Shireoaks, Worksop, S81 8BW.

These financial statements have been prepared in sterling, which is the functional currency of the entity.

The principal activity of the charity is to promote the best renal medical practice and treatment and to support the related needs of those suffering from kidney disease or renal failure.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

National Kidney Federation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Going concern

After making appropriate enquiries, the trustees have a reasonable expectation that the charitable company has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements

2.3 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Charity has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the Charity, can be reliably measured.

Grants are included in the Statement of Financial Activities on a receivable basis. The balance of income received for specific purposes but not expended during the period is shown in the relevant funds on the Balance Sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Where entitlement occurs before income is received, the income is accrued.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

Page 26

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

2. Accounting policies (continued)

2.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on raising funds includes all expenditure incurred by the Charity to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

Page 27

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

2. Accounting policies (continued)

2.6 Intangible assets and amortisation

Intangible assets costing £1,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Amortisation is provided on intangible assets at rates calculated to write off the cost of each asset on a straight-line basis over its expected useful life.

Amortisation is provided on the following bases:

NKF database software - 10 % straight line
Website development - 20 % straight line

2.7 Tangible fixed assets and depreciation

Tangible fixed assets costing £1,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.

Depreciation is provided on the following bases:

Long-term leasehold property - 2% on cost Fixtures and fittings - 5 - 20% on cost

2.8 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of Financial Activities.

2.9 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Page 28

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

2. Accounting policies (continued)

2.10 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.11 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

2.12 Pensions

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.

2.13 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 29

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

3. Income from donations and legacies

Unrestricted
funds
2023
£
Donations
104,916
Legacies
359,295
Grants
24,488
Total 2023
488,699
Total 2022
462,361		 Restricted
funds
2023
£
35,584
-
-
35,584
76,624		 Total
funds
2023
£
140,500
359,295
24,488
524,283
538,985		 Total
funds
2022
£
186,558
263,501
88,926
538,985

4. Income from charitable activities

Unrestricted
funds
2023
£
Income from charitable activities - NKF Annual Patient Event
57,862
Income from charitable activities - Publications and
information
8,079
Income from charitable activities - Patient support
4,662
Total 2023
70,603
Total 2022
23,058		 Total
funds
2023
£
57,862
8,079
4,662
70,603
23,058		 Total
funds
2022
£
5,000
12,711
5,347
23,058

Page 30

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

5. Income from other trading activities

Income from fundraising events

Unrestricted
funds
2023
£
Annual Lottery
20,520
Merchandise
11,620
Other fundraising
102,487
Total 2023
134,627
Total 2022
132,963
6.
Investment income
Unrestricted
funds
2023
£
Investment income
15,336
Total 2022
4,413		 Total
funds
2023
£
20,520
11,620
102,487
134,627
132,963
Total
funds
2023
£
15,336
4,413		 Total
funds
2022
£
20,713
9,709
102,541
132,963
Total
funds
2022
£
4,413

Page 31

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

7. Expenditure on raising funds

Costs of raising voluntary income

Unrestricted
funds
2023
£
Lottery Costs
8,101
Merchandise and volunteer costs
6,574
Other fundraising costs
24,391
Costs of raising voluntary income - wages and salaries
45,360
Costs of raising voluntary income - NI
4,616
Costs of raising voluntary income - pension costs
3,629
Total 2023
92,671
Total 2022
111,866		 Total
funds
2023
£
8,101
6,574
24,391
45,360
4,616
3,629
92,671
111,866		 Total
funds
2022
£
7,891
7,840
45,446
42,700
4,573
3,416
111,866

Page 32

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

8. Analysis of expenditure on charitable activities

Summary by fund type

Unrestricted
funds
2023
£
NKF Annual Patient Event
42,141
Publications and information
191,060
Patient support
119,511
Other conferences & meetings
107,929
Total 2023
460,641
Total 2022
316,979		 Restricted
funds
2023
£
10,049
-
25,535
-
35,584
76,624		 Total
2023
£
52,190
191,060
145,046
107,929
496,225
393,603		 Total
2022
£
21,320
164,628
125,083
82,572
393,603

Page 33

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

9. Analysis of expenditure by activities

NKF Patient Events
Publications and information
Patient support
Other conferences & meetings
Total 2023
Total 2022		 Activities
undertaken
directly
2023
£
32,543
89,884
25,535
24,988
172,950
101,886		 Support
costs
2023
£
19,647
101,176
119,511
82,941
323,275
291,717		 Total
funds
2023
£
52,190
191,060
145,046
107,929
496,225
393,603		 Total
funds
2022
£
21,320
164,628
125,083
82,572
393,603

Analysis of support costs

Support costs
Total 2022		 NKF Annual
Conference
2023
Information
and
publications
2023
£
£
19,647
101,176
17,990
91,480		 Patient
support
2023
Other
conferences
2023
£
£
119,511
82,941
108,449
73,798		 Total
funds
2023
£
323,275
291,717		 Total
funds
2022
£
291,717

Page 34

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

10. Auditor's remuneration - Governance costs

The auditor's remuneration amounts to an auditor fee of £5,500 ( 2022 - £5,500 ).

11. Staff costs

Wages and salaries
Social security costs
Contribution to defined contribution pension schemes		 2023
£
255,033
19,671
24,494
299,198		 2022
£
227,836
17,530
20,660
266,026

The average number of persons employed by the Charity during the year was as follows:

2023 2022
No. No.
Total Staff 9 9

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

2023 2022
No. No.
In the band £60,001 - £70,000 1 -

Remuneration and benefits received (including Employer's National Insurance) by 3 members of key management personnel amounted to £162,402 (2022 - remuneration to 3 members of staff amounting to a total of £149,870).

12. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2022 - £NIL) .

During the year ended 31 December 2023, expenses totalling £ 571 were reimbursed or paid directly to 4 Trustees (2022 - £NIL to Trustee) . These expenses related to travel costs incurred for Executive Meetings.

Page 35

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

13. Intangible assets

Cost
At 1 January 2023
At 31 December 2023
Amortisation
At 1 January 2023
Charge for the year
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022		 NKF
database
software
£
15,480
15,480
3,096
1,548
4,644
10,836
12,384		 Website
devt.
£
9,000
9,000
9,000
-
9,000
-
-		 Total
£
24,480
24,480
12,096
1,548
13,644
10,836
12,384

Page 36

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

14. Tangible fixed assets

Cost or valuation
At 1 January 2023
At 31 December 2023
Depreciation
At 1 January 2023
Charge for the year
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022		 Long-term
leasehold
property
£
530,465
530,465
277,317
6,401
283,718
246,747
253,148		 Fixtures and
fittings
£
76,793
76,793
66,277
3,744
70,021
6,772
10,516		 Total
£
607,258
607,258
343,594
10,145
353,739
253,519
263,664

The charity obtained a professional valuation during the year ended 31 December 2022 which indicated that the valuation of the leasehold property was £300,000. The charity's accounting policy states that tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses.

As this value is in excess of the carrying value of the asset, and as a result does not indicate impairment is required, the property will continue to be held under the historical cost model.

Page 37

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

15.
Fixed asset investments
Cost or valuation
At 1 January 2023
Additions
Revaluations
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022		 Listed
investments
£
1,404,919
13,284
145,058
1,563,261
1,563,261
1,404,919

The investments of the charity entirely comprise investments through CCLA. The historic cost of the investments is £1,251,835 (2022: £1,238,551).

16. Debtors

Due within one year
Trade debtors
Other debtors
Prepayments and accrued income		 2023
£
6,789
1,420
25,495
33,704		 2022
£
1,769
213
30,581
32,563

Page 38

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

17. Creditors: Amounts falling due within one year

Other taxation and social security
Trade creditors
Accruals and deferred income
Deferred income at 1 January 2023
Resources deferred during the year
Amounts released from previous periods		 2023
£
6,173
5,749
16,802
28,724
2023
£
14,579
10,460
(14,579)
10,460		 2022
£
4,900
9,233
23,238
37,371
2022
£
7,789
14,579
(7,789)
14,579

Deferred income relates to advertisements received in advance of the forthcoming year.

Page 39

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

18. Statement of funds

Statement of funds - current year

Unrestricted
funds
Designated
funds
young@NKF
Major home
therapies project
Property and
investment cash
reserve
General funds
General funds
Development
plan
Total
Unrestricted
funds
Endowment
funds
Endowment
Fund
Restricted
funds
Grants for
helpline income		 Balance at 1
January
2023
£
12,640
-
-
12,640
1,811,786
-
1,811,786
1,824,426
490,977
-		 Income
£
-
-
-
-
709,265
-
709,265
709,265
-
35,584		 Expenditure
£
-
-
-
-
(553,312)
-
(553,312)
(553,312)
-
(35,584)		 Transfers
in/out
£
-
150,000
350,000
500,000
(1,500,000)
1,000,000
(500,000)
-
-
-		 Gains/
(Losses)
£
-
-
-
-
121,940
-
121,940
121,940
23,118
-		 Balance at
31
December
2023
£
12,640
150,000
350,000
512,640
589,679
1,000,000
1,589,679
2,102,319
514,095
-

Page 40

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

18. Statement of funds (continued)

Total of funds 2,315,403 744,849 (588,896) - 145,058 2,616,414

Designated funds

young@NKF fund - represents the value of income received for the support of young kidney patients. Major home therapies project - represents a cash reserve to cover involvement with a major home therapies project over the next 5 years.

Property and investment cash reserve - represents a cash reserve to cover any possible adverse movements in property and investment values.

Restricted funds

Grants for Helpline Income- represents the value of grants received to help with the operation of the charity's helpline. These grants have been spent in full.

Page 41

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

18. Statement of funds (continued)

Statement of funds - prior year

Unrestricted funds
Designated funds
young@NKF
General funds
General funds
Total Unrestricted funds
Endowment funds
Endowment Fund
Restricted funds
Grants for helpline income
Grants for magazine income
Total of funds		 Balance at
1 January
2022
£
13,862
1,656,107
1,669,969
569,962
-
-
-
2,239,931		 Income
£
-
622,795
622,795
-
54,064
22,560
76,624
699,419		 Expenditure
£
(1,222)
(427,623)
(428,845)
-
(54,064)
(22,560)
(76,624)
(505,469)		 Gains/
(Losses)
£
-
(39,493)
(39,493)
(78,985)
-
-
-
(118,478)		 Balance at
31
December
2022
£
12,640
1,811,786
1,824,426
490,977
-
-
-
2,315,403

Page 42

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

19. Summary of funds

Summary of funds - current year

Designated
funds
General funds
Endowment
funds
Restricted funds		 Balance at 1
January
2023
£
12,640
1,811,786
490,977
-
2,315,403		 Income
£
-
709,265
-
35,584
744,849
Balance at
1 January
2022
£
13,862
1,656,107
569,962
-
2,239,931		 Expenditure
£
-
(553,312)
-
(35,584)
(588,896)
Income
£
-
622,795
-
76,624
699,419		 Transfers
in/out
£
500,000
(500,000)
-
-
-
Expenditure
£
(1,222)
(427,623)
-
(76,624)
(505,469)		 Gains/
(Losses)
£
-
121,940
23,118
-
145,058
Gains/
(Losses)
£
-
(39,493)
(78,985)
-
(118,478)		 Balance at
31
December
2023
£
512,640
1,589,679
514,095
-
2,616,414
Balance at
31
December
2022
£
12,640
1,811,786
490,977
-
2,315,403
Summary of funds - prior year
Designated funds
General funds
Endowment funds
Restricted funds

Page 43

(A Company Limited by Guarantee)

NATIONAL KIDNEY FEDERATION

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

20. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2023
£
Tangible fixed assets
253,519
Intangible fixed assets
10,836
Fixed asset investments
1,049,166
Current assets
817,522
Creditors due within one year
(28,724)
Total
2,102,319
Analysis of net assets between funds - prior year
Unrestricted
funds
2022
£
Tangible fixed assets
263,664
Intangible fixed assets
12,384
Fixed asset investments
913,942
Current assets
671,807
Creditors due within one year
(37,371)
Total
1,824,426		 Endowment
funds
2023
£
-
-
514,095
-
-
514,095
Endowment
funds
2022
£
-
-
490,977
-
-
490,977		 Total
funds
2023
£
253,519
10,836
1,563,261
817,522
(28,724)
2,616,414
Total
funds
2022
£
263,664
12,384
1,404,919
671,807
(37,371)
2,315,403

Page 44

NATIONAL KIDNEY FEDERATION (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

21. Reconciliation of net movement in funds to net cash flow from operating activities

Net income for the year (as per Statement of Financial Activities)
Adjustments for:
Depreciation charges
Amortisation charges
Gains on investments
Dividends, interests and rents from investments
Decrease/(increase) in debtors
Increase/(decrease) in creditors
Net cash provided by operating activities
22.
Analysis of cash and cash equivalents
Cash in hand
Total cash and cash equivalents		 2023
£
301,011
10,145
1,548
(145,058)
(15,336)
(1,141)
(8,649)
142,520
2023
£
783,818
783,818		 2022
£
75,472
9,969
1,548
118,478
(4,413)
8,693
16,111
225,858
2022
£
639,244
639,244

Page 45

NATIONAL KIDNEY FEDERATION

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

23. Analysis of changes in net debt

Cash at bank and in hand At 1
January
2023
£
639,244
639,244		 Cash flows
£
144,574
144,574		 At 31
December
2023
£
783,818
783,818

24. Operating lease commitments

The Charity had no commitments under non-cancellable operating leases at 31 December 2023.

25. Related party transactions

No transactions required to be disclosed under FRS 102 have been incurred by the charity during the year ended 31 December 2023 or the year ended 31 December 2022.

Page 46